Simmons Zachary, Towfighi Javad
Salt Lake City, UT From the *Division of Neurology and the daggerDepartment of Pathology, Penn State College of Medicine, Hershey, Pennsylvania.
J Clin Neuromuscul Dis. 2002 Mar;3(3):122-32. doi: 10.1097/00131402-200203000-00005.
Sporadic inclusion body myositis (s-IBM) is a common but under-recognized myopathy in individuals over 50 years of age. An awareness of the clinical phenotype and of the electrodiagnostic and histopathologic features should lead to improved recognition, and should minimize confusion with polymyositis, motor neuron disease, and other neuromuscular disorders. Treatment efficacy has been difficult to judge because of the insidious progression of the disease over many years, but immunomodulating therapy is generally less effective than in polymyositis and dermatomyositis, and may not be effective at all in many patients. The hereditary inclusion body myopathies (h-IBM) are a heterogeneous group of recessively and dominantly inherited vacuolar myopathies that share some histologic features with s-IBM. Oxidative stress may play a role in the pathogenesis of both s-IBM and h-IBM.
散发性包涵体肌炎(s-IBM)是一种常见但未被充分认识的肌病,好发于50岁以上人群。了解其临床表型、电诊断及组织病理学特征,有助于提高诊断率,并减少与多发性肌炎、运动神经元病及其他神经肌肉疾病的混淆。由于该病多年来隐匿进展,治疗效果难以判断,但免疫调节治疗通常不如在多发性肌炎和皮肌炎中有效,且在许多患者中可能根本无效。遗传性包涵体肌病(h-IBM)是一组隐性和显性遗传的空泡性肌病,与s-IBM有一些组织学特征相同。氧化应激可能在s-IBM和h-IBM的发病机制中起作用。